Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics

Pharmacogenomics J. 2003;3(1):11-3. doi: 10.1038/sj.tpj.6500158.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Attention Deficit Disorder with Hyperactivity / genetics*
  • DNA-Binding Proteins / genetics
  • Dopamine Plasma Membrane Transport Proteins
  • Humans
  • Membrane Glycoproteins*
  • Membrane Transport Proteins*
  • Methylphenidate / therapeutic use
  • Nerve Tissue Proteins*
  • Pharmacogenetics / methods*
  • Pharmacogenetics / trends*
  • Saccharomyces cerevisiae Proteins*

Substances

  • DAT1 protein, S cerevisiae
  • DNA-Binding Proteins
  • Dopamine Plasma Membrane Transport Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Saccharomyces cerevisiae Proteins
  • Methylphenidate